Enfusion Inc’s recent filing unveils that its Director Somers Deirdre acquired Company’s shares for reported $62441.0 on Apr 15 ’25. In the deal valued at $10.79 per share,5,787 shares were bought.
Then, Bastone Bronwen sold 3,126 shares, generating $35,558 in total proceeds. Upon selling the shares at $11.38, the Chief People Officer now owns 221,875 shares.
Before that, Campobasso Matthew sold 1,695 shares. Enfusion Inc shares valued at $19,281 were divested by the General Counsel at a price of $11.38 per share. As a result of the transaction, Campobasso Matthew now holds 70,946 shares, worth roughly $0.77 million.
A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in late February from “a Neutral” to “a Sell”. JP Morgan also remained covering ENFN and has decreased its forecast on January 30, 2024 with a “an Underweight” recommendation from previously “Neutral” rating. UBS started covering the stock on November 07, 2023. It rated ENFN as “a Neutral”.
Price Performance Review of ENFN
On Tuesday, Enfusion Inc [NYSE:ENFN] saw its stock jump 1.02% to $10.92. Over the last five days, the stock has gained 4.20%. Enfusion Inc shares have risen nearly 6.02% since the year began. Nevertheless, the stocks have risen 14.11% over the past one year. While a 52-week high of $11.80 was reached on 02/20/25, a 52-week low of $7.83 was recorded on 01/02/25. SMA at 50 days reached $11.12, while 200 days put it at $9.81.
Levels Of Support And Resistance For ENFN Stock
The 24-hour chart illustrates a support level at 10.79, which if violated will result in even more drops to 10.67. On the upside, there is a resistance level at 11.00. A further resistance level may holdings at 11.09. The Relative Strength Index (RSI) on the 14-day chart is 48.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 28.57%. Stochastics %K at 63.95% indicates the stock is a holding.
How much short interest is there in Enfusion Inc?
A steep rise in short interest was recorded in Enfusion Inc stocks on 2025-03-31, growing by 0.35 million shares to a total of 1.3 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 0.95 million shares. There was a rise of 27.2%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 03, 2023 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating along with a $11 price target.
